CCTG Investigational New Drug Committee Chair Dr. Quincy Chu, Investigational New Drug Committee Chair Dr. Quincy Chu is a medical oncologist who specializes in thoracic malignancies as well as early phase clinical trials. He received his M.D degree from University of Toronto in Ontario, Canada. He is an investigator with the Cross Cancer Institute’s New Drug Development Program, and is also the incoming CCTG Investigational New Drug Committee Chair. “Canadian researchers working together on CCTG collaborative clinical trials get novel and effective, therapy to the patient faster, learn from each other and then achieve even more.” Research Interests: Thoracic malignancies and sarcomas Phase I/II clinical trials of innovative anti-cancer agents Molecular determinants of response and toxicities of innovative anti-cancer agents; Publications Not all publications available on PubMed CCTG Investigational New Drug Committee
